The urgency to #PrioritizeCRC by Congress is undeniable.
Join advocates from across the country in Washington, D.C., from March 10-12, and share your story to educate members of Congress on issues impacting you and the #ColorectalCancer community!
Time is running out - register now to be a part of the change!
https://t.co/SizLCluXaN
Join us for a recap of the Early-Onset #ColorectalCancer Think Tank! We'll share key themes, findings, and provide a platform for your voice. Medical professionals and advocates, let's have an inclusive discussion!
https://t.co/iXLXvsZ71U #PathtoaCure
Thank you, @RepDonaldPayne, for addressing @UHC's
#PriorAuth plan that will cause delays in care for patients at high risk for #ColorectalCancer and exacerbate existing sociodemographic disparities in care and outcomes. #StopUHC
The #FightColorectalCancer app connects survivors & caregivers with others in our community who've been through similar experiences.
You can:
๐ฌ Share information or news
โ Ask questions or give advice
๐ Gain support and friendship
โจ Find inspiration and hope
๐ CONGRATULATIONS ๐ to Phuong Gallagher and Mary McCabe, RN, MA, the 2023 Stovall Award winners! We are grateful for their commitment to survivors and tireless work to improve cancer care.
Read more about their work at https://t.co/GTpmWCOCwx
We have the attention of @UHC! ๐ข Take action and follow up about their Advance Notification Program. Take one minute to help... #StopUHC https://t.co/E18dk7tOdQ
โOne of the most important areas of research right now is learning how we can take successes in things like cancer immunotherapy and advance that into #ColorectalCancer.โ -Dr. Fields, MD
Learn more: https://t.co/eJD4MOZdHY #ASCO23#ASCO
The FDA has granted approval for a combination therapy for patients who qualify, with one criteria being HER2-positive metastatic CRC. HER2-positive is a biomarker initially discovered in breast cancer but also present in about 3-5% of CRC cases. #ASCO23 https://t.co/q4p7uk6Ahk
Phuong Gallagher (@CancerInsider) discussed the impact of Research Advocates within the #ColorectalCancer community, and how to become a part of the Research Advocates Training and Support Program that informs the scientific community. #ASCO23#ASCO https://t.co/4vIFAu5TUX
So proud of @FightCRC Research Advocate (RATS), @Winni195!! Your advocacy is SAVING LIVES and inspiring so many others! Thank you for your leadership and expertise in this fight!!
Introducing Wenora Johnson, @FacingOurRisk Board President: Her commitment to the well-being of others who have gone through similar experiences is truly inspiring. Please join us in thanking Wenora for her leadership and service to FORCE. @Winni195
Recently, @UHC announced plans to require #PriorAuth for many colonoscopy procedures, including high-risk patients such as those with a family history, genetic condition or history of polyps.
Take Action! https://t.co/DBfjgln9nu
.@UHC your proposed GI endoscopy program that requires #PriorAuth will create harmful barriers for patients including those with a family history of CRC, genetic condition or history of polyps.
Take Action! https://t.co/wmSMg0p6lM
Making progress against colorectal cancer requires all of us. A new coalition led by @FightCRC, chaired by @Freenome + catalyzed by the #CancerMoonshot will develop a blueprint for equitable colorectal cancer screening in America. Join them in stepping up: https://t.co/vlBPPJaQJ5
PAY ATTENTION @POTUS@VP Colorectal cancer is the ONLY top 5 cancer that doesnโt have a research program at the @DeptofDefense! THIS IS NOT RIGHT! #FightColorectalCancer